Advertisement

Related Videos

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Deborah Collyar: What's In It for Patients?

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Advertisement

Advertisement




Oct
11
Today In Oncology
Prior Authorization Is Burdensome for Patients, Resulting in Treatment Delays, Financial Strain, and Stress
Antidepressants May Improve Surgical Outcomes in Patients With GI Cancer and Depression
Patients Value Communication Skills From Cancer Surgeons Across Six Key Areas
Study Identifies Rectal Bleeding as Key Predictor of Early-Onset Colorectal Cancer
Financial Toxicity Tied to Increased Risk of Mortality Among Patients With Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo